Clinical

Dataset Information

0

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer


ABSTRACT: The primary objective of this study is to compare the effect of panitumumab versus cetuximab on overall survival (OS) for chemorefractory metastatic colorectal cancer (mCRC) among patients with wild-type Kirsten rat Sarcoma-2 virus (KRAS) tumors.

DISEASE(S): Malignant Neoplasm Of Rectum,Metastatic Colorectal Cancer,Colon Cancer,Previously Treated, Wild-type Kras, Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2079859 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2111195 | ecrin-mdr-crc
| 2071598 | ecrin-mdr-crc
| 2035328 | ecrin-mdr-crc
| 2181884 | ecrin-mdr-crc
| 2401536 | ecrin-mdr-crc
2023-12-11 | GSE245560 | GEO
2023-12-11 | GSE245819 | GEO
| 2309880 | ecrin-mdr-crc
| 2179129 | ecrin-mdr-crc
2016-05-05 | E-MTAB-3548 | biostudies-arrayexpress